2004•PubMedRequires access

[Value of fluorine-18 fluorode oxyglucose-positron emission tomography in patients with small cell lung cancer].

Chang-hai Yu, Tao Wang, Dayi Yin, Yue Sun, Jiahe Tian, Shulin Yao

Abstract

OBJECTIVE: To investigate the value of fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging in patients with small cell lung cancer. METHODS: From February 2000 to July 2003, 17 patients with small cell lung cancer were imaged with FDG-PET. FDG-PET scans were analyzed by visual method. The FDG-PET results were compared with the pathological results and results of follow-up survey. RESULTS: 15 primary tumors were all FDG avid. By visual method 63 areas metastatic lymph nodes in 15 cases were revealed and more distant metastases outside the hemithoraxes were confirmed by FDG-PET than by routine examinations. FDG-PET corrected the diagnosis 5 cases from local disease (LD) to extended disease (ED). CONCLUSION: FDG-PET has great value in staging and treatment of patients with small cell lung cancer.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Positron emission tomography, Lung cancer, Nuclear medicine, Fluorodeoxyglucose, Standardized uptake value, Radiology, Lung